Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.966 USD | -2.07% | -18.47% | -53.75% |
Mar. 18 | Transcript : Eyenovia, Inc., Q4 2023 Earnings Call, Mar 18, 2024 | |
Mar. 18 | Eyenovia, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-53.75% | 46.74M | |
+34.84% | 701B | |
+26.24% | 571B | |
+1.12% | 381B | |
+20.77% | 334B | |
+17.07% | 319B | |
+1.04% | 210B | |
+2.86% | 210B | |
-6.20% | 201B | |
-3.18% | 157B |
- Stock
- Equities
- Stock Eyenovia, Inc. - Nasdaq
- News Eyenovia, Inc.
- Eyenovia : FDA Reclassifies Eyenovia's MydCombi as Drug-Device Combination Product